Antibody Drug Conjugates Market Overview | Key Players & Insights

Antibody-drug conjugates (ADCs) mark a significant breakthrough in the realm of targeted biopharmaceutical therapies. These innovative therapeutics combine monoclonal antibodies, which selectively identify surface antigens on specific tumor cells, with potent anti-cancer agents that are linked via a chemical connector.